Vonvendi is now approved for routine prophylaxis to reduce bleeding frequency in adults with all types of VWD (Type 1, 2, and 3). The Food and Drug Administration (FDA) has expanded the approval of ...
When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images/ bluecinema Von Willebrand disease in dogs is the most common inherited ...
(RTTNews) - Takeda Pharmaceutical Company Limited (TAK, TKPHF, 4502.T) announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ...
Could your heavy flow be cause for concern? Sherri Ozawa, MSN, RN, tells The Post that serious blood loss during menstruation could be a symptom of von Willebrand disease, a blood disorder that ...
Findings showed that routine prophylaxis with wilate resulted in an 84% reduction in mean total ABRs compared with on-demand treatment. The Food and Drug Administration (FDA) has expanded the approval ...
Vonvendi is a lab-made version of von Willebrand factor (VWF), a protein your body needs for blood to clot. Affecting more than 3 million people in the U.S, von Willebrand disease (VWD) is a common ...
Star Therapeutics, a late clinical-stage biotechnology company focused on the discovery and development of life-changing ...
(Family Features) “I wanted to live my life like there was nothing wrong, but the fear was always there.” That’s how 65-year-old Frank described life with von Willebrand disease (VWD), the most common ...
Proceeds to support continued clinical advancement of lead program, VGA039, a first-in-class antibody targeting protein S for the treatment of bleeding disorders, starting with von Willebrand disease ...
Von Willebrand factor (VWF) is a protein crucial to the blood clotting process. If you don’t have enough of this protein, or if it doesn’t work as it’s supposed to, you may have von Willebrand disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results